EUVIMEDEUVIMED entdecken
Crossref

Detection of antinuclear antibodies: a survey done by the European Organsation for External Quality Assurance Providers in Laboratory Medicine

Dina Patel, Stéphanie Albarède, Werner Klotz, Annechien J A Lambeck, Lucile Musset, Zoe Vayanos, Manfred Herold

Laboratory Medicine · 2025

DOI: 10.1093/labmed/lmaf011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Laboratory Medicine, 2025. Verfasst von Dina Patel und 6 weiteren Autor:innen. Beteiligte Einrichtung: UK NEQAS Immunology, Immunochemistry & Allergy, Northern General Hospital, Sheffield, United Kingdom. Hauptthemen laut MEDLINE: Antibodies, Antinuclear, Quality Assurance, Health Care, Laboratories, Clinical. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

A questionnaire was sent to immunology laboratories worldwide by the European Organisation for External Quality Assurance Providers in Laboratory Medicine to evaluate current practice with regard to how antinuclear antibodies (ANAs) are routinely tested in clinical laboratories.

Methods

In total, 494 questionnaires were returned from 44 countries. Of these, 379 provided sufficient information to be included in the analysis.

Results

Indirect immunofluorescence on HEp-2 cells is still the most common method to test ANAs and is used by 330 of our 379 respondents. The most common (60%) screening dilution is 1:80, followed by 1:160 (15%) and, in equal amounts, 1:40 and 1:100 (8% each). In most laboratories, ANA-positive samples are further diluted to an end titer of 1:1280 (40%), 1:2560 (21%), 1:5120 (16%), or 1:640 (19%). An increasing number of laboratories (178/330) use the International Consensus on ANA Patterns (ICAP) nomenclature to describe the immunofluorescence pattern on HEp-2 cells. In countries with the most respondents, the percentage of laboratories accredited to EN International Organization for Standardization (ISO) 15189 (in Britain, BS EN ISO 15189, which is a British standard as well as a European standard as well as an ISO standard with identical content) is between 8% (Belgium) and 60% (France). There was no difference in the portion of accredited laboratories between university hospitals, nonuniversity hospitals, and private laboratories.

Discussion

Indirect immunofluorescence continues to be the most frequently used technique for ANA testing in laboratories. The increasing number of laboratories using the ICAP classification reflects an ongoing harmonization of describing ANA patterns on HEp-2 cell substrates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, AntinuclearQuality Assurance, Health CareLaboratories, ClinicalHumansSurveys and QuestionnairesEuropeFluorescent Antibody Technique, Indirect

Stichwörter der Autor:innen

ANAICAPautoantibodiesimmunofluorescence

Substanzen

Antibodies, Antinuclear

Autor:innen und Institutionen

  • UK NEQAS Immunology, Immunochemistry & Allergy, Northern General Hospital, Sheffield, United Kingdom.
  • Toulouse Center for Quality Control in Medical Laboratories (CTCB), Toulouse, France.
  • Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.
  • Department of Laboratory Medicine, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands.
  • Department of Immunology, Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.
  • Autoimmunity expert at Biologie Prospective, Nancy, France.

Zitieren

APA

Patel, D., Albarède, S., Klotz, W., Lambeck, A. J. A., Musset, L., Vayanos, Z., & Herold, M. (2025). Detection of antinuclear antibodies: a survey done by the European Organsation for External Quality Assurance Providers in Laboratory Medicine. Laboratory Medicine. https://doi.org/10.1093/labmed/lmaf011

Vancouver

Patel D, Albarède S, Klotz W, Lambeck AJA, Musset L, Vayanos Z, et al. Detection of antinuclear antibodies: a survey done by the European Organsation for External Quality Assurance Providers in Laboratory Medicine. Laboratory Medicine. 2025. doi:10.1093/labmed/lmaf011

BibTeX
@article{Patel2025,
  author = {Patel, Dina and Albarède, Stéphanie and Klotz, Werner and Lambeck, Annechien J A and Musset, Lucile and Vayanos, Zoe and Herold, Manfred},
  title = {Detection of antinuclear antibodies: a survey done by the European Organsation for External Quality Assurance Providers in Laboratory Medicine},
  journal = {Laboratory Medicine},
  year = {2025},
  doi = {10.1093/labmed/lmaf011}
}
Kostenlos starten →